ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Propranolol Effective, Well-Tolerated for Symptomatic IH

by Nancy M. Baumann, MD • February 1, 2010

  • Tweet
  • Email
Print-Friendly Version

Will propranolol become the mainstay of treatment for symptomatic infantile hemangiomas (IH)?

Background: IH are the most common tumor of infancy, affecting four to 10 percent of infants. Spontaneous involution is the expected outcome, but nearly 10 percent cause symptoms warranting early therapy. Propranolol was serendipitously found to hasten IH involution, with fewer side effects than traditional corticosteroid therapy, in an index case and 10 additional cases reported in the New England Journal of Medicine (2008;358:2649-2651).

You Might Also Like

  • How Should Propranolol Be Initiated for Infantile Hemangiomas: Inpatient Versus Outpatient?
  • Propranolol Reduces Size and Blood Vessel Density of Infantile Hemangiomas
  • An Unofficial First-Line Treatment: Propranolol gains widespread use for infantile hemangiomas
  • Is Voice Therapy Effective in Managing Vocal Fold Nodules in Children?
Explore This Issue
February 2010

Study Design: Observational case series of 32 patients, including previously reported 11.

Setting: Children’s Hospital, Pellegrin Hospital and Saint Andre Hospital, Bordeaux, France; Purpan Hospital, Toulouse, France; Strasbourg Hospital, Strasbourg, France; Fort de France Hospital, Fort de France, France.

Synopsis: Propranolol (2 mg/kg/day) was given during the proliferative phase (n=27, mean 4.2 m) or plateau phase (n=5, mean 31 m) for a mean of six months. Softening and lightening of the hemangioma was immediately noted in all patients. Dyspnea, ocular opening and hemodynamics were the most common indications for starting therapy and improved within the first week. Ulcerations healed within two months. Ultrasound showed 40 percent regression in maximal thickness (n=11, 60 days). Corticosteroids were first used in 13 patients with minimal response and all were stopped within the first month of starting propranolol.

Adverse effects were rare. It is unclear whether vital signs were monitored for the first six or 24 hours; however, transient hypotension was only reported in one patient. Propranolol was stopped after three months in another patient due to wheezing. Therapy was concluded in 16 patients at the time of the report and had to be resumed in two patients with symptomatic regrowth.

Bottom Line: Propranolol appears to be an effective and well-tolerated as a first-line treatment for symptomatic IH. Prospective studies comparing efficacy and side effects with corticosteroids are needed.

Citation: Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics. 2009;124:e423-31.

Filed Under: Literature Reviews, Pediatric, Pediatric, Practice Focus Tagged With: IH, propranololIssue: February 2010

You Might Also Like:

  • How Should Propranolol Be Initiated for Infantile Hemangiomas: Inpatient Versus Outpatient?
  • Propranolol Reduces Size and Blood Vessel Density of Infantile Hemangiomas
  • An Unofficial First-Line Treatment: Propranolol gains widespread use for infantile hemangiomas
  • Is Voice Therapy Effective in Managing Vocal Fold Nodules in Children?

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Otolaryngologists Have a Major Role to Play in Treating COVID-19 Long-Haulers
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.